FindTrial
Sign In

Protective effects of Xuebijing on acute kidney injury in patients with community-acquired pneumonia

The effect of Xuebijing on acute kidney injury in patients with community-acquired pneumonia: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106746
Enrollment
Unknown
Registered
2025-07-29
Start date
2025-07-12
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Control group:None
Xuebingjing group:None

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Hospitalized patients over 18 years old who meet the primary diagnosis of community-acquired pneumonia.

Exclusion criteria

Exclusion criteria: 1. Acute kidney injury occurred upon admission; 2. Incomplete clinical data; 3. End stage renal disease or regular dialysis; 4. Creatinine levels were measured less than twice during hospitalization.

Design outcomes

Primary

MeasureTime frame
Incidence rate of acute kidney injury in different stages;—

Secondary

MeasureTime frame
Incidence rates of acute kidney injury in different stages;Rate of renal replacement therapy;In-hospital mortality rate;—

Countries

China

Contacts

Public ContactDawei Chen

Nanjing First Hospital

chendawei@njmu.edu.cn+86 153 6611 0015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026